Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes

Ann Surg Oncol. 2014 Aug;21(8):2594-600. doi: 10.1245/s10434-014-3633-6. Epub 2014 Mar 18.

Abstract

Purpose: The purpose of the present study was to analyze clinicopathologic features and long-term prognosis of gastric stump cancer (GSC) arising in the remnant stomach 5 years or later after partial gastrectomy for benign disease.

Methods: We reviewed the results of 176 patients resected with curative intent for GSC at 8 Italian centers belonging to the Italian Research Group for Gastric Cancer (GIRCG). The median (range) follow-up time for surviving patients was 71.2 (6-207) months.

Results: One hundred forty-six patients were men, the mean age at the time of diagnosis was 69.2 years, and the great majority (167 cases) underwent Billroth II reconstruction. R0 resection was achieved in 158 (90 %) patients, and in 94 (53 %) lymph node dissection was ≥D2. Postoperative mortality and complication rates were 6.2 and 43.2 %, respectively. T1 tumor was diagnosed in 45 (25 %) cases. Lymph node metastases were evident in 86 patients (49 %). Thirteen patients had involvement of the jejunal mesentery nodes (pJN+); five cases were T2-T3 and eight cases were T4. Overall 5-year survival rate was 53.1 %. Five-year survival rates were 68.1, 37.8, and 33.1 % for pT1, pT2-3, and pT4 tumors, respectively (P = 0.001). Five-year survival rate was 56.5 % for node-negative tumors (pN0), 32.3 % for tumors with nodal metastases without involvement of jejunal mesentery nodes (pN+), and 17.1 % for tumors with involvement of jejunal mesentery nodes (pJN+) (P = 0.002).

Conclusions: Our study suggests that an aggressive surgical approach can achieve a satisfactory outcome in GSC.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Gastrectomy / adverse effects*
  • Gastric Stump / pathology*
  • Gastric Stump / surgery
  • Humans
  • Lymph Node Excision / adverse effects*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neoplasm, Residual / etiology
  • Neoplasm, Residual / mortality
  • Neoplasm, Residual / pathology*
  • Postoperative Complications / etiology
  • Postoperative Complications / mortality
  • Postoperative Complications / pathology*
  • Precancerous Conditions / mortality
  • Precancerous Conditions / pathology
  • Precancerous Conditions / surgery*
  • Prognosis
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Survival Rate